| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4ea2c80e66e2b310938851055478f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d17663f8447ad0d0d0642d05d4aaee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84bf3df3c637864eb72d38d2bb2eee7a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_872e2a51d9d90eb71ff0ec2f03631de4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40477c1b7081d119c2cc039abd7b1592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b87c149cbac90c189451c7aa80be5c3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3a4dc9d05f94fcb8f2a23a45f2c98fd |
| publicationDate |
2015-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015081290-A1 |
| titleOfInvention |
Methods for modulating angiogenesis of cancers refractory to anti-vegf treatment |
| abstract |
A method for modulating angiogenesis in a cancer or tumor refractory to anti-VEGF, including identifying a cancer cell as being referactory to anti-VEGF, and then contacting the cancer cell refractory to anti-VEGF with an effective amount of an agent that modulates interaction between Gal1 or a Gal1 fragment and the natural binding partner of Gal1 or the Gal1 fragment to thereby modulate angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723972-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015191536-A1 |
| priorityDate |
2013-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |